Acessibilidade / Reportar erro

Clinical trial with sulpiride

Treatment with sulpiride was carried out either orally or intramusculary in a group of 39 patients suffering from a variety of psychiatric conditions. Duration of treatment ranged between 20 and 90 days of hos- pitalization and dose administered was 1200 mg/day. Secondary reactions were minimal and no effects were observed on the blood crasis. The clinical results showed a satisfactory effect over anxiety, reactive disjunction and over certain types of delirious and hallucinatory activities.


Academia Brasileira de Neurologia - ABNEURO R. Vergueiro, 1353 sl.1404 - Ed. Top Towers Offices Torre Norte, 04101-000 São Paulo SP Brazil, Tel.: +55 11 5084-9463 | +55 11 5083-3876 - São Paulo - SP - Brazil
E-mail: revista.arquivos@abneuro.org